Page last updated: 2024-12-07

dabequin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

dabequin: 4-amino substituted benzoquinoline [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID124331
MeSH IDM0065295

Synonyms (10)

Synonym
g 800
g-800
1,2-ethanediamine, n'-benzo(g)quinolin-4-yl-n,n-diethyl-, phosphate (1:2)
dabequin
triethylamine, 2-(benzo(g)quinolin-4-ylamino)-, diphosphate
56548-51-7
AKOS024355076
DTXSID90205108
n'-benzo[g]quinolin-4-yl-n,n-diethyl-1,2-ethanediamine bis(phosphate)
n-benzo[g]quinolin-4-yl-n',n'-diethylethane-1,2-diamine;phosphoric acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.56%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]